Phase I–II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer

Combination chemotherapy with irinotecan (CPT-11) and platinum compounds is effective for treating cervical cancer. Nedaplatin (254-S) is a new cisplatin analogue that achieves a high response rate (53%) in patients with primary cervical cancer. We performed a phase I–II study of combination chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuda, H, Hashiguchi, Y, Nishimura, S, Miyama, M, Nakata, S, Kawamura, N, Negoro, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747698/
https://www.ncbi.nlm.nih.gov/pubmed/15292935
http://dx.doi.org/10.1038/sj.bjc.6602076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747698/
https://www.ncbi.nlm.nih.gov/pubmed/15292935
http://dx.doi.org/10.1038/sj.bjc.6602076

Ejemplares similares